{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T12:16:17Z","timestamp":1783426577319,"version":"3.54.6"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.msard.2026.107305","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T06:44:00Z","timestamp":1780641840000},"page":"107305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["TLR3 polymorphism protects against multiple sclerosis onset but not progression in Egyptian patients"],"prefix":"10.1016","volume":"112","author":[{"given":"Esraa","family":"Mohsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesham","family":"Haffez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selwan","family":"Hamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taghrid S.","family":"El-Mahdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2026.107305_bib0001","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.3390\/ijms25115711","article-title":"From immunity to neurogenesis: toll-like receptors as versatile regulators in the nervous system","volume":"25","author":"Abarca-Merlin","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.msard.2026.107305_bib0002","doi-asserted-by":"crossref","first-page":"S831","DOI":"10.1007\/s100720070021","article-title":"A prospective study on the prognosis of multiple sclerosis","volume":"21","author":"Amato","year":"2000","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.msard.2026.107305_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e11680","article-title":"Association of TLR7 and TLR9 genes polymorphisms in Egyptian patients with systemic lupus erythematosus","volume":"8","author":"Azab","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.msard.2026.107305_bib0004","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.antiviral.2013.05.008","article-title":"Association of single nucleotide polymorphism rs3775291 in the coding region of the TLR3 gene with predisposition to tick-borne encephalitis in a Russian population","volume":"99","author":"Barkhash","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.msard.2026.107305_bib0005","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1177\/13524585211005367","article-title":"Misdiagnosis of multiple sclerosis: time for action","volume":"27","author":"Brownlee","year":"2021","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2026.107305_bib0006","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.msard.2019.05.027","article-title":"Complete sequence analysis of human toll-like receptor 3 gene in natural killer cells of multiple sclerosis patients","volume":"33","author":"Deeba","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107305_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003336","article-title":"MicroRNA-3148 modulates allelic expression of toll-like receptor 7 variant associated with systemic Lupus Erythematosus","volume":"9","author":"Deng","year":"2013","journal-title":"PLoS. Genet."},{"key":"10.1016\/j.msard.2026.107305_bib0008","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/iji.12531","article-title":"RNA receptors, TLR3 and TLR7, are potentially associated with SLE clinical features","volume":"48","author":"Elloumi","year":"2021","journal-title":"Int. J. Immunogenet."},{"key":"10.1016\/j.msard.2026.107305_bib0009","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jneuroim.2009.04.008","article-title":"Multiple sclerosis and polymorphisms of innate pattern recognition receptors TLR1-10, NOD1-2, DDX58, and IFIH1","volume":"212","author":"Enevold","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2026.107305_bib0010","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1177\/1352458510373264","article-title":"Polymorphisms of innate pattern recognition receptors, response to interferon-beta and development of neutralizing antibodies in multiple sclerosis patients","volume":"16","author":"Enevold","year":"2010","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2026.107305_bib0011","article-title":"Multiple sclerosis","volume":"4","author":"Filippi","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.msard.2026.107305_bib0012","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.cell.2020.02.041","article-title":"Toll-like receptors and the control of immunity","volume":"180","author":"Fitzgerald","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.msard.2026.107305_bib0013","series-title":"JAMA Neurology","first-page":"841","article-title":"Association of intrathecal immunoglobulin G synthesis with disability worsening in multiple sclerosis","author":"Gasperi","year":"2019"},{"key":"10.1016\/j.msard.2026.107305_bib0014","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1515\/revneuro-2014-0026","article-title":"The role of toll-like receptors in multiple sclerosis and possible targeting for therapeutic purposes","volume":"0","author":"Gooshe","year":"2014","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.msard.2026.107305_bib0015","doi-asserted-by":"crossref","first-page":"7756","DOI":"10.3390\/ijms26167756","article-title":"Refining prognostic factors in adult-onset multiple sclerosis: a narrative review of current insights","volume":"26","author":"Guerra","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.msard.2026.107305_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/0037-8682-0026-2020","article-title":"Association of tlr3 single nucleotide polymorphisms with susceptibility to htlv-1 infection in iranian asymptomatic blood donors","volume":"53","author":"Habibabadi","year":"2020","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.msard.2026.107305_bib0017","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s00415-008-0743-8","article-title":"Contribution of relapses to disability in multiple sclerosis","volume":"255","author":"Hirst","year":"2008","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2026.107305_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105703","article-title":"Disease modifying treatment guidelines for multiple sclerosis in the United Arab Emirates","volume":"88","author":"Jacob","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107305_bib0019","article-title":"Toll-like receptor-7 gene polymorphism at 3\u2212 UTR (rs3853839) in relation to Systemic Lupus Erythematosus pathogenesis in Iraqi patients","volume":"33","author":"Jassim","year":"2023","journal-title":"Gene Rep."},{"key":"10.1016\/j.msard.2026.107305_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103029","article-title":"Relapses add to permanent disability in relapsing multiple sclerosis patients","volume":"53","author":"Koch-Henriksen","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107305_bib0021","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2026.107305_bib0022","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrneurol.2012.168","article-title":"Progressive multiple sclerosis: pathology and pathogenesis","volume":"8","author":"Lassmann","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2026.107305_bib0023","article-title":"Associations of toll-like receptor polymorphisms with systemic lupus erythematosus: a meta-analysis","volume":"10","author":"Lee","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.msard.2026.107305_bib0024","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41590-018-0135-x","article-title":"Reassessing B cell contributions in multiple sclerosis","volume":"19","author":"Li","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.msard.2026.107305_bib0025","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3390\/brainsci14060564","article-title":"The spatiotemporal expression of SOCS3 in the brainstem and spinal cord of amyotrophic lateral sclerosis mice","volume":"14","author":"Lin","year":"2024","journal-title":"Brain Sci."},{"key":"10.1016\/j.msard.2026.107305_bib0026","doi-asserted-by":"crossref","DOI":"10.2991\/978-94-6463-932-2","article-title":"New insight into the role of SOCS family in immune regulation and autoimmune pathogenesis","author":"Liu","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.msard.2026.107305_bib0027","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1093\/brain\/awac016","article-title":"How patients with multiple sclerosis acquire disability","volume":"145","author":"Lublin","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.msard.2026.107305_bib0028","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cytogfr.2014.07.013","article-title":"IL-17 and related cytokines involved in the pathology and immunotherapy of multiple sclerosis: Current and future developments","volume":"25","author":"Luchtman","year":"2014","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.msard.2026.107305_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00386","article-title":"TLR-dependent human mucosal epithelial cell responses to microbial pathogens","volume":"5","author":"McClure","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2026.107305_bib0030","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S1474-4422(25)00270-4","article-title":"Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria","volume":"24","author":"Montalban","year":"2025","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2026.107305_bib0031","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.autrev.2011.10.007","article-title":"The biological significance of TLR3 variant, L412F, in conferring susceptibility to cutaneous candidiasis, CMV and autoimmunity","volume":"11","author":"Nahum","year":"2012","journal-title":"Autoimmun Rev."},{"key":"10.1016\/j.msard.2026.107305_bib0032","first-page":"S1","article-title":"Multiple sclerosis: diagnosis and differential diagnosis","volume":"55","author":"\u00d6merhoca","year":"2018","journal-title":"Noropsikiyatri Ars."},{"key":"10.1016\/j.msard.2026.107305_bib0033","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.expneurol.2014.06.013","article-title":"Expression of Suppressor of Cytokine Signaling-3 (SOCS3) and its role in neuronal death after complete spinal cord injury","volume":"261","author":"Park","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.msard.2026.107305_bib0034","article-title":"Effects of reducing suppressors of cytokine signaling-3 (SOCS3) expression on dendritic outgrowth and demyelination after spinal cord injury","volume":"10","author":"Park","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.msard.2026.107305_bib0035","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/gut.2007.129478","article-title":"Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C","volume":"57","author":"Persico","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.msard.2026.107305_bib0036","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122686","article-title":"Male sex is independently associated with faster disability accumulation in relapse-onset MS but not in primary progressive MS","volume":"10","author":"Ribbons","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.msard.2026.107305_bib0037","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jneuroim.2014.05.013","article-title":"Quantitative analysis of the suppressors of cytokine signaling 1 and 3 in peripheral blood leukocytes of patients with multiple sclerosis","volume":"273","author":"Sede\u00f1o-Monge","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2026.107305_bib0038","doi-asserted-by":"crossref","first-page":"15838","DOI":"10.1073\/pnas.1001337107","article-title":"Sex-specific association of X-linked toll-like receptor 7 (TLR7) with male systemic lupus erythematosus","volume":"107","author":"Shen","year":"2010","journal-title":"Proc. Natl. Acad. Sci. u S. a"},{"key":"10.1016\/j.msard.2026.107305_bib0039","doi-asserted-by":"crossref","first-page":"329","DOI":"10.26565\/2312-5675-2025-29-04","article-title":"Diagnostic pitfalls in multiple sclerosis: how to avoid mistakes","volume":"12","author":"Shulga","year":"2025","journal-title":"Psychiatry Neurol. Med. Psychol."},{"key":"10.1016\/j.msard.2026.107305_bib0040","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2147\/VHRM.S405039","article-title":"The potential of single nucleotide polymorphisms (SNPs) as biomarkers and their association with the increased risk of coronary heart disease: a systematic review","volume":"19","author":"Sitinjak","year":"2023","journal-title":"Vasc. Health Risk Manag. Vol."},{"key":"10.1016\/j.msard.2026.107305_bib0041","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.727987","article-title":"SOCS proteins in immunity, inflammatory diseases, and immune-related cancer","volume":"8","author":"Sobah","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.msard.2026.107305_bib0042","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1179\/174313209X405155","article-title":"Investigation of the [-\/A]8 and C1236T genetic variations within the human toll-like receptor 3 gene for association with multiple sclerosis","volume":"32","author":"Szvetko","year":"2010","journal-title":"Neurol. Res."},{"key":"10.1016\/j.msard.2026.107305_bib0043","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2026.107305_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2022.107528","article-title":"Early onset multiple sclerosis and the effect of disease onset age on neurological disability in multiple sclerosis","volume":"224","author":"Usta","year":"2023","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.msard.2026.107305_bib0045","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1007\/s10753-024-02195-z","article-title":"Combined bulk and single-cell transcriptomic analysis to reveal the potential influences of intestinal inflammatory disease on multiple sclerosis","volume":"48","author":"Xu","year":"2025","journal-title":"Inflammation"},{"key":"10.1016\/j.msard.2026.107305_bib0046","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.3390\/ijms23115877","article-title":"Current and future biomarkers in multiple sclerosis","volume":"23","author":"Yang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.msard.2026.107305_bib0047","article-title":"Toll-like receptors gene polymorphisms in autoimmune disease","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2026.107305_bib0048","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3389\/fnmol.2019.00314","article-title":"Inflammatory role of TLR-MyD88 signaling in multiple sclerosis","volume":"12","author":"Zheng","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.msard.2026.107305_bib0049","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01799","article-title":"IgG index revisited: diagnostic utility and prognostic value in multiple sclerosis","volume":"11","author":"Zheng","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2026.107305_bib0050","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1177\/13524585241274527","article-title":"Misdiagnosis and underdiagnosis of multiple sclerosis: a systematic review and meta-analysis","volume":"30","author":"Z\u00fcrrer","year":"2024","journal-title":"Mult. Scler. J."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482600341X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482600341X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T11:33:49Z","timestamp":1783424029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221103482600341X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":50,"alternative-id":["S221103482600341X"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107305","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TLR3 polymorphism protects against multiple sclerosis onset but not progression in Egyptian patients","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107305","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107305"}}